Exact Mass: 603.2374376
Exact Mass Matches: 603.2374376
Found 265 metabolites which its exact mass value is equals to given mass value 603.2374376
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
N-[(1R)-1-[3-(4-Ethoxyphenyl)-4-oxopyrido[2,3-d]pyrimidin-2-yl]ethyl]-N-(pyridin-3-ylmethyl)-2-[4-(trifluoromethoxy)phenyl]acetamide
Damme
D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D018377 - Neurotransmitter Agents > D018847 - Opioid Peptides D018377 - Neurotransmitter Agents > D004745 - Enkephalins
Diethylaminoethyl-dextran
Draflazine
C78274 - Agent Affecting Cardiovascular System > C78322 - Cardiotonic Agent C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors D020011 - Protective Agents > D002316 - Cardiotonic Agents D002317 - Cardiovascular Agents
D-alpha-N-acetyl-delta-N-acetyl-delta-N-hydroxyornithine-D-serine-cyclo(L-delta-N-hydroxyornithine-L-delta-N-acetyl-delta-N-hydroxyornithine)|erythrochelin
Cys Arg Tyr Tyr
Cys Tyr Arg Tyr
Cys Tyr Tyr Arg
Asp Phe His Trp
Asp Phe Trp His
Asp His Phe Trp
Asp His Trp Phe
Asp Gln Arg Trp
Asp Gln Trp Arg
Asp Arg Gln Trp
Asp Arg Trp Gln
Asp Trp Phe His
Asp Trp His Phe
Asp Trp Gln Arg
Asp Trp Arg Gln
Glu His Arg Tyr
Glu His Tyr Arg
Glu Asn Arg Trp
Glu Asn Trp Arg
Glu Arg His Tyr
Glu Arg Asn Trp
Glu Arg Trp Asn
Glu Arg Tyr His
Glu Trp Asn Arg
Glu Trp Arg Asn
Glu Tyr His Arg
Glu Tyr Arg His
Phe Asp His Trp
Phe Asp Trp His
Phe Phe Gln Tyr
Phe Phe Tyr Gln
Phe His Asp Trp
Phe His Trp Asp
Phe Gln Phe Tyr
Phe Gln Tyr Phe
Phe Trp Asp His
Phe Trp His Asp
Phe Tyr Phe Gln
Phe Tyr Gln Phe
His Asp Phe Trp
His Asp Trp Phe
His Glu Arg Tyr
His Glu Tyr Arg
His Phe Asp Trp
His Phe Trp Asp
His Met Met Trp
His Met Trp Met
His Arg Glu Tyr
His Arg Tyr Glu
His Val Trp Tyr
His Val Tyr Trp
His Trp Asp Phe
His Trp Phe Asp
His Trp Met Met
His Trp Val Tyr
His Trp Tyr Val
His Tyr Glu Arg
His Tyr Arg Glu
His Tyr Val Trp
His Tyr Trp Val
Lys Met Tyr Tyr
Lys Tyr Met Tyr
Lys Tyr Tyr Met
Met His Met Trp
Met His Trp Met
Met Lys Tyr Tyr
Met Met His Trp
Met Met Trp His
Met Gln Tyr Tyr
Met Trp His Met
Met Trp Met His
Met Tyr Lys Tyr
Met Tyr Gln Tyr
Met Tyr Tyr Lys
Met Tyr Tyr Gln
Asn Glu Arg Trp
Asn Glu Trp Arg
Asn Arg Glu Trp
Asn Arg Trp Glu
Asn Val Trp Trp
Asn Trp Glu Arg
Asn Trp Arg Glu
Asn Trp Val Trp
Asn Trp Trp Val
Gln Asp Arg Trp
Gln Asp Trp Arg
Gln Phe Phe Tyr
Gln Phe Tyr Phe
Gln Met Tyr Tyr
Gln Arg Asp Trp
Gln Arg Trp Asp
Gln Trp Asp Arg
Gln Trp Arg Asp
Gln Tyr Phe Phe
Gln Tyr Met Tyr
Gln Tyr Tyr Met
Arg Cys Tyr Tyr
Arg Asp Gln Trp
Arg Asp Trp Gln
Arg Glu His Tyr
Arg Glu Asn Trp
Arg Glu Trp Asn
Arg Glu Tyr His
Arg His Glu Tyr
Arg His Tyr Glu
Arg Asn Glu Trp
Arg Asn Trp Glu
Arg Gln Asp Trp
Arg Gln Trp Asp
Arg Trp Asp Gln
Arg Trp Glu Asn
Arg Trp Asn Glu
Arg Trp Gln Asp
Arg Tyr Cys Tyr
Arg Tyr Glu His
Arg Tyr His Glu
Arg Tyr Tyr Cys
Val His Trp Tyr
Val His Tyr Trp
Val Asn Trp Trp
Val Trp His Tyr
Val Trp Asn Trp
Val Trp Trp Asn
Val Trp Tyr His
Val Tyr His Trp
Val Tyr Trp His
Trp Asp Phe His
Trp Asp His Phe
Trp Asp Gln Arg
Trp Asp Arg Gln
Trp Glu Asn Arg
Trp Glu Arg Asn
Trp Phe Asp His
Trp Phe His Asp
Trp His Asp Phe
Trp His Phe Asp
Trp His Met Met
Trp His Val Tyr
Trp His Tyr Val
Trp Met His Met
Trp Met Met His
Trp Asn Glu Arg
Trp Asn Arg Glu
Trp Asn Val Trp
Trp Asn Trp Val
Trp Gln Asp Arg
Trp Gln Arg Asp
Trp Arg Asp Gln
Trp Arg Glu Asn
Trp Arg Asn Glu
Trp Arg Gln Asp
Trp Val His Tyr
Trp Val Asn Trp
Trp Val Trp Asn
Trp Val Tyr His
Trp Trp Asn Val
Trp Trp Val Asn
Trp Tyr His Val
Trp Tyr Val His
Tyr Cys Arg Tyr
Tyr Cys Tyr Arg
Tyr Glu His Arg
Tyr Glu Arg His
Tyr Phe Phe Gln
Tyr Phe Gln Phe
Tyr His Glu Arg
Tyr His Arg Glu
Tyr His Val Trp
Tyr His Trp Val
Tyr Lys Met Tyr
Tyr Lys Tyr Met
Tyr Met Lys Tyr
Tyr Met Gln Tyr
Tyr Met Tyr Lys
Tyr Met Tyr Gln
Tyr Gln Phe Phe
Tyr Gln Met Tyr
Tyr Gln Tyr Met
Tyr Arg Cys Tyr
Tyr Arg Glu His
Tyr Arg His Glu
Tyr Arg Tyr Cys
Tyr Val His Trp
Tyr Val Trp His
Tyr Trp His Val
Tyr Trp Val His
Tyr Tyr Cys Arg
Tyr Tyr Lys Met
Tyr Tyr Met Lys
Tyr Tyr Met Gln
Tyr Tyr Gln Met
Tyr Tyr Arg Cys
BenzaMide, N-[1,2-dihydro-1-[2-C-Methyl-3,5-O-[1,1,3,3-tetrakis(1-Methylethyl)-1,3-disiloxanediyl]-β-D-arabinofuranosyl]-2-oxo-4-pyriMidinyl]-
Draflazine
C78274 - Agent Affecting Cardiovascular System > C78322 - Cardiotonic Agent C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors D020011 - Protective Agents > D002316 - Cardiotonic Agents D002317 - Cardiovascular Agents
2-(Diethylamino)-4,5,6,7-tetrahydroxy-8-[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyoctan-3-one
platensimycin B4
C30H37NO12 (603.2315642000001)
A monosaccharide derivative of platensimycin isolated from Streptomyces platensis.
1-[(2R,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-(3,5-dimethyl-4-isoxazolyl)urea
N-[(5S,6R,9R)-8-(1,3-benzodioxol-5-ylmethyl)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1,3-benzodioxole-5-carboxamide
C33H37N3O8 (603.2580522000001)
1-(3,5-dimethyl-4-isoxazolyl)-3-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]urea
C30H36F3N5O5 (603.2668401999999)
1-(3,5-dimethyl-4-isoxazolyl)-3-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]urea
C30H36F3N5O5 (603.2668401999999)
1-[(2S,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(3,5-dimethyl-4-isoxazolyl)urea
1-(3,5-dimethyl-4-isoxazolyl)-3-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]urea
C30H36F3N5O5 (603.2668401999999)
1-(3,5-dimethyl-4-isoxazolyl)-3-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]urea
C30H36F3N5O5 (603.2668401999999)
1-(3,5-dimethyl-4-isoxazolyl)-3-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]urea
C30H36F3N5O5 (603.2668401999999)
1-[(2S,3R)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(3,5-dimethyl-4-isoxazolyl)urea
1-(3,5-dimethyl-4-isoxazolyl)-3-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]urea
C30H36F3N5O5 (603.2668401999999)
1-(3,5-dimethyl-4-isoxazolyl)-3-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]urea
C30H36F3N5O5 (603.2668401999999)
1-(3,5-dimethyl-4-isoxazolyl)-3-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]urea
C30H36F3N5O5 (603.2668401999999)
1-(3,5-dimethyl-4-isoxazolyl)-3-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]urea
C30H36F3N5O5 (603.2668401999999)
1-[(2S,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(3,5-dimethyl-4-isoxazolyl)urea
1-(3,5-dimethyl-4-isoxazolyl)-3-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]urea
C30H36F3N5O5 (603.2668401999999)
1-[(2R,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(3,5-dimethyl-4-isoxazolyl)urea
1-[(2R,3R)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(3,5-dimethyl-4-isoxazolyl)urea
1-(3,5-dimethyl-4-isoxazolyl)-3-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]urea
C30H36F3N5O5 (603.2668401999999)
1-(3,5-dimethyl-4-isoxazolyl)-3-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]urea
C30H36F3N5O5 (603.2668401999999)
1-(3,5-dimethyl-4-isoxazolyl)-3-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]urea
C30H36F3N5O5 (603.2668401999999)
1-[(2S,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-(3,5-dimethyl-4-isoxazolyl)urea
1-[(2S,3R)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-(3,5-dimethyl-4-isoxazolyl)urea
5-aminopentyl beta-D-glucopyranosyl-(1->3)-beta-D-glucopyranuronosyl-(1->4)-beta-D-glucopyranoside
Adagrasib
Adagrasib (MRTX849) is a potent, orally-available, and mutation-selective covalent inhibitor of KRAS G12C with potential antineoplastic activity. Adagrasib covalently binds to KRAS G12C at the cysteine at residue 12, locks the protein in its inactive GDP-bound conformation, and inhibits KRAS-dependent signal transduction[1][2].
4-methylaconitane-1,6,8,10,13,14,15,16,18-nonol; (1α,6α,14α,15α,16β)-form,o6,o16,o18-tri-me,14-benzoyl,8-ac
C31H41NO11 (603.2679476000001)
{"Ingredient_id": "HBIN010679","Ingredient_name": "4-methylaconitane-1,6,8,10,13,14,15,16,18-nonol; (1\u03b1,6\u03b1,14\u03b1,15\u03b1,16\u03b2)-form,o6,o16,o18-tri-me,14-benzoyl,8-ac","Alias": "NA","Ingredient_formula": "C31H41NO11","Ingredient_Smile": "NA","Ingredient_weight": "603.66","OB_score": "NA","CAS_id": "83145-43-1","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "7780","PubChem_id": "NA","DrugBank_id": "NA"}
3-[(3-{5,9-dimethyl-4-oxo-8-oxatetracyclo[7.2.1.1⁷,¹⁰.0¹,⁶]tridec-2-en-5-yl}-1-hydroxypropylidene)amino]-2-hydroxy-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}benzoic acid
C30H37NO12 (603.2315642000001)
(1s,3r,5s,7r,9s,10r,12r,14r,15s,18r,19r,20r,22s,23r)-10,20,22-trihydroxy-7,18-dimethyl-19-(5-oxo-2h-furan-3-yl)-5'h-4,6,11-trioxaspiro[hexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacosane-9,2'-[1,3]thiazole]-14-carbaldehyde
C31H41NO9S (603.2501896000001)
(1s,4s,7s,9s,10s,25s,26r)-4-hydroxy-7-(hydroxymethyl)-7-methoxy-17,17,24,24-tetramethyl-8,16-dioxa-3,22,28-triazanonacyclo[23.6.1.0¹,²⁸.0³,²⁶.0⁴,⁹.0¹⁰,²⁶.0¹¹,²³.0¹²,²¹.0¹⁵,²⁰]dotriaconta-11(23),12,14,18,20-pentaene-2,5,27-trione
C33H37N3O8 (603.2580522000001)
(1s,3r,5s,7r,9s,10r,12r,14r,15s,18r,19r,22s,23r)-4',10,22-trihydroxy-7,18-dimethyl-19-(5-oxo-2h-furan-3-yl)-5'h-4,6,11-trioxaspiro[hexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacosane-9,2'-[1,3]thiazole]-14-carbaldehyde
C31H41NO9S (603.2501896000001)
1,5-dimethyl (2s)-2-[(6as)-5-chloro-9-[(2s,3r)-3-methoxy-2-methylbutanoyl]-6a-methyl-3-[(1e,3s)-3-methylpent-1-en-1-yl]-6,8-dioxofuro[2,3-h]isoquinolin-2-yl]pentanedioate
4-hydroxy-7-(hydroxymethyl)-7-methoxy-17,17,24,24-tetramethyl-8,16-dioxa-3,22,28-triazanonacyclo[23.6.1.0¹,²⁸.0³,²⁶.0⁴,⁹.0¹⁰,²⁶.0¹¹,²³.0¹²,²¹.0¹⁵,²⁰]dotriaconta-11(23),12,14,18,20-pentaene-2,5,27-trione
C33H37N3O8 (603.2580522000001)
3-({3-[(5s)-5,9-dimethyl-4-oxo-8-oxatetracyclo[7.2.1.1⁷,¹⁰.0¹,⁶]tridec-2-en-5-yl]-1-hydroxypropylidene}amino)-2-hydroxy-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}benzoic acid
C30H37NO12 (603.2315642000001)
4',10,22-trihydroxy-7,18-dimethyl-19-(5-oxo-2h-furan-3-yl)-5'h-4,6,11-trioxaspiro[hexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacosane-9,2'-[1,3]thiazole]-14-carbaldehyde
C31H41NO9S (603.2501896000001)
(3s,6s,7r)-6-hydroxy-8-methyl-3-(3,4,5-trimethoxybenzoyloxy)-7-{[(2e)-3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]oxy}-8-azabicyclo[3.2.1]octan-8-ium-8-olate
C30H37NO12 (603.2315642000001)
(2r)-n-[(1r)-1-({3-[(2s,5s)-3,6-dihydroxy-5-[3-(n-hydroxyacetamido)propyl]-2,5-dihydropyrazin-2-yl]propyl}(hydroxy)carbamoyl)-2-hydroxyethyl]-5-(n-hydroxyacetamido)-2-[(1-hydroxyethylidene)amino]pentanimidic acid
10,20,22-trihydroxy-7,18-dimethyl-19-(5-oxo-2h-furan-3-yl)-5'h-4,6,11-trioxaspiro[hexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacosane-9,2'-[1,3]thiazole]-14-carbaldehyde
C31H41NO9S (603.2501896000001)